Gapping down
In reaction to earnings/guidance:
- QTWO -9.3%, STMP -8.7%, AM -8.7%, NICE -8.5%, IQ -8.2%, SPWR -7.4%, SM -6.8%, GEL -6.3%, MD -6%, FSLY -5.7%, WMT -4.7%, UCTT -4.5%, ORAN -3.5%, VC -3.3%, SAM -3.1%, BCS -3%, ALB -2.8%, SNN -2.8%, RBBN -2.7%, AEL -2.6%, TROX -2.1% (also increases dividend by 14%), VTR -2%, CDE -1.7%, H -1.7%, ET -1.6%, HL -1.5%, TXG -1.4%, SNPS -1.3%, CS -1.2%, BIDU -1.1%, STNG -1%
Other news:
- DPW -11.5% (announces that as of January 29, 2021, the Company had purchased an aggregate of 295,000 shares of common stock or 9.96% equity interest in NTN Buzztime)
- SITM -8.4% (prices offering of 3,000,000 shares of its common stock at $127.00 per share)
- MTEM -7% (prices public offering of 6.0 mln common shares at $12.65/share)
- VERU -6.2% (prices offering of 6,451,613 shares of its common stock at $15.50 per share)
- SI -4.5% (underwriters agreed to release up to 15% of common stock held by directors and executive officers)
- BNTX -2.5% (BNTX and PFE publish results for BNT162b2 )
- KAR -1.9% (to combine TradeRev and BacklotCars into single marketplace)
- ZG -1.8% (files mixed securities shelf offering and enters into equity distribution agreement to sell up to $1 bln of Class C capital stock)
- UGI -1.6% (to bring significant RNG supplies into its system)
- BRP -1.4% (to acquire Medicare Help Now)
- PDAC -1.3% (TechMet funded Li-Cycle entered into a definitive business combination agreement with Peridot Acquisition Corp)
- MNSO -1.2% (to transform into a new retail platform, incubate more sub-brands)
- YMAB -1.1% (prices offering of 2,439,025 shares of its common stock at $41.00 per share)
- BGNE -1% (BGNE and Boston Immune enter into an option and license agreement)
Analyst comments:
- FTI -4.6% (downgraded to Neutral from Buy at UBS)
- KTOS -2.2% (downgraded to Neutral from Outperform at Robert W. Baird)